Skip to content

Intellepedia

IP News Center

  • Home
  • Patents
  • Trademarks
  • Copyrights
  • Designs
  • Trade Secrets

Tag: natco vs bayer

Compulsory Licensing in India

Author: Intellepedia
September 30, 2015
Patents

This article analyses the evolution and practice of compulsory licensing in India, focusing on landmark cases and their effects on patent activity. It assesses whether compulsory licensing influences innovation and discusses the operational challenges within the Indian Patent Office.

READ MORE Read more about Compulsory Licensing in India

Categories

Trending IP Articles

AbbVie’s Patent Refusal Upheld over Impermissible Shift from Treatment to Product Claims

Astrology Meets IP – Zodiac Strategies for the Week Ahead (May 25–31)

Astrology Meets IP – Zodiac Strategies for the Week Ahead (June 1–7)

Interim Relief to FDC in KROMALITE Trademark Dispute

When Dye Becomes Decisive: Patent Infringement, Equivalence, and Estoppel

Can a Pre-Grant Opposition Survive After Patent Grant?

Isha Foundation Secures Interim Relief in Defamation Case, Next Hearing in September

Astrology Meets IP – Zodiac Strategies for the Week Ahead (June 8–14)

ITC’s Nicotine Device Patent Rejection on Public Health Grounds Set Aside

Patent Claim Amendments – Court’s observation of amendments to systems, methods and use claims

Visit BananaIP Counsels Website

https://www.bananaip.com

Disclaimer

Intellepedia is an independent knowledge-sharing initiative. All opinions expressed by individual authors are their own and do not reflect the views or positions of any organisation or firm with which they may be affiliated.

We welcome your questions, suggestions, and corrections. If you are interested in contributing as an author, please write to us. Intellectual property experts and professionals from all related fields are welcome to participate.

Contribute to Intellepedia

contact@intellepedia.org

Archives

  • Home
  • Patents
  • Trademarks
  • Copyrights
  • Designs
  • Trade Secrets

© 2025 Intellepedia. All Rights Reserved.

Terms of Use | Privacy Policy | Accessibility Statement